Information Provided By:
Fly News Breaks for March 7, 2018
DGX
Mar 7, 2018 | 08:00 EDT
As reported earlier, Argus analyst Jasper Hellweg upgraded Quest Diagnostics to Buy from Hold with a price target of $116. Hellweg says he has a positive view of the company's cash generation, cost controls, and share repurchases, while also pointing to its first dividend increase since Q1 of 2016 last month. Longer term, Hellweg expects added benefits for Quest Diagnostics from its recent acquisitions and a lower tax rate. The analyst also sees the current valuation of the stock as compelling.
News For DGX From the Last 2 Days
There are no results for your query DGX